215 related articles for article (PubMed ID: 22865929)
41. Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.
Zhang P; Gao K; Jin X; Ma J; Peng J; Wumaier R; Tang Y; Zhang Y; An J; Yan Q; Dong Y; Huang H; Yu L; Wang C
Cell Death Dis; 2015 Mar; 6(3):e1687. PubMed ID: 25766326
[TBL] [Abstract][Full Text] [Related]
42. Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.
Herynk MH; Beyer AR; Cui Y; Weiss H; Anderson E; Green TP; Fuqua SA
Mol Cancer Ther; 2006 Dec; 5(12):3023-31. PubMed ID: 17172405
[TBL] [Abstract][Full Text] [Related]
43. Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.
Okada M; Ohtake F; Nishikawa H; Wu W; Saeki Y; Takana K; Ohta T
Mol Endocrinol; 2015 Nov; 29(11):1646-57. PubMed ID: 26389696
[TBL] [Abstract][Full Text] [Related]
44. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
45. E6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors.
Ramamoorthy S; Nawaz Z
Nucl Recept Signal; 2008 Apr; 6():e006. PubMed ID: 18432313
[TBL] [Abstract][Full Text] [Related]
46. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
[TBL] [Abstract][Full Text] [Related]
47. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
48. Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.
Marconett CN; Sundar SN; Poindexter KM; Stueve TR; Bjeldanes LF; Firestone GL
Mol Biol Cell; 2010 Apr; 21(7):1166-77. PubMed ID: 20130088
[TBL] [Abstract][Full Text] [Related]
49. Intrinsic AhR function underlies cross-talk of dioxins with sex hormone signalings.
Ohtake F; Baba A; Fujii-Kuriyama Y; Kato S
Biochem Biophys Res Commun; 2008 Jun; 370(4):541-6. PubMed ID: 18358233
[TBL] [Abstract][Full Text] [Related]
50. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
[TBL] [Abstract][Full Text] [Related]
51. The pure estrogen receptor antagonist ICI 182,780 promotes a novel interaction of estrogen receptor-alpha with the 3',5'-cyclic adenosine monophosphate response element-binding protein-binding protein/p300 coactivators.
Jaber BM; Gao T; Huang L; Karmakar S; Smith CL
Mol Endocrinol; 2006 Nov; 20(11):2695-710. PubMed ID: 16840538
[TBL] [Abstract][Full Text] [Related]
52. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.
Tateishi Y; Kawabe Y; Chiba T; Murata S; Ichikawa K; Murayama A; Tanaka K; Baba T; Kato S; Yanagisawa J
EMBO J; 2004 Dec; 23(24):4813-23. PubMed ID: 15538384
[TBL] [Abstract][Full Text] [Related]
53. UBE3A/E6-AP regulates cell proliferation by promoting proteasomal degradation of p27.
Mishra A; Godavarthi SK; Jana NR
Neurobiol Dis; 2009 Oct; 36(1):26-34. PubMed ID: 19591933
[TBL] [Abstract][Full Text] [Related]
54. Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation.
Fan M; Nakshatri H; Nephew KP
Mol Endocrinol; 2004 Nov; 18(11):2603-15. PubMed ID: 15284335
[TBL] [Abstract][Full Text] [Related]
55. Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction.
Smith CL; DeVera DG; Lamb DJ; Nawaz Z; Jiang YH; Beaudet AL; O'Malley BW
Mol Cell Biol; 2002 Jan; 22(2):525-35. PubMed ID: 11756548
[TBL] [Abstract][Full Text] [Related]
56. Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development.
Yoo HM; Kang SH; Kim JY; Lee JE; Seong MW; Lee SW; Ka SH; Sou YS; Komatsu M; Tanaka K; Lee ST; Noh DY; Baek SH; Jeon YJ; Chung CH
Mol Cell; 2014 Oct; 56(2):261-274. PubMed ID: 25219498
[TBL] [Abstract][Full Text] [Related]
57. Ubiquitin-dependent proteolysis of trihydrophobin 1 (TH1) by the human papilloma virus E6-associated protein (E6-AP).
Yang Y; Liu W; Zou W; Wang H; Zong H; Jiang J; Wang Y; Gu J
J Cell Biochem; 2007 May; 101(1):167-80. PubMed ID: 17131388
[TBL] [Abstract][Full Text] [Related]
58. KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.
Anbalagan M; Carrier L; Glodowski S; Hangauer D; Shan B; Rowan BG
Breast Cancer Res Treat; 2012 Apr; 132(2):391-409. PubMed ID: 21509526
[TBL] [Abstract][Full Text] [Related]
59. The estrogen receptor (ER)alpha variant Delta5 exhibits dominant positive activity on ER-regulated promoters in endometrial carcinoma cells.
Bryant W; Snowhite AE; Rice LW; Shupnik MA
Endocrinology; 2005 Feb; 146(2):751-9. PubMed ID: 15528307
[TBL] [Abstract][Full Text] [Related]
60. ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts.
Lambertini E; Tavanti E; Torreggiani E; Penolazzi L; Gambari R; Piva R
J Cell Physiol; 2008 Jul; 216(1):101-10. PubMed ID: 18247370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
